Ep. 106 - China's C-suite Hears FDA, Plus AACR, ARPA-H
BioCentury This Week
00:00
Accelerated Approval
There's a house hearing this week to consider 22 bills related to industry. Some of them will make it into the user fee reauthorization, including competing approaches on accelerated approval. I think that what's going to be probably more important than where it's located, is who heads it, and how much autonomy and how much stature the first director of orge has.
Transcript
Play full episode
